Month: January 2026

27 JANUARY 2026 NORTHERN 3 VCT PLC ADMISSION OF FURTHER SHARES TO TRADING In conformity with The Public Offers and Admissions to Trading Regulations 2024 issued by the Financial Conduct Authority (the “FCA”), Northern 3 VCT PLC with the legal entity identifier 213800MWOA6W221PI432 (the “Company”) notifies the market that a further 403,442 ordinary shares with a nominal value of 5p each and ISIN GB0031152027 were admitted to trading on the London Stock Exchange’s market for listed securities and to the Official List of the FCA on 27 January 2026. These further shares are fungible with the existing ordinary shares already admitted to trading. Following this admission of shares there are 159,364,444 ordinary shares admitted to trading. This notification covers all admissions up to and including 27 January 2026. Enquiries: Sarah Williams /...

Parties are collaborating in a multi-phase plan to assess Eye-Net’s collision prevention V2X technology to protect both vehicles and vulnerable road users Ness Ziona, Israel, Jan. 27, 2026 (GLOBE NEWSWIRE) — Foresight Autonomous Holdings Ltd. (Nasdaq and TASE: FRSX) (“Foresight” or the “Company”), an innovator in automotive vision solutions, recently announced that its majority-owned subsidiary, Eye-Net Mobile Ltd. (“Eye-Net”), has advanced its strategic collaboration in Japan with SoftBank Corp. (“SoftBank”) to further validate Eye-Net’s vehicle-to-everything (“V2X”) collision prediction and prevention solutions technology. The joint initiative aims to enhance road safety and operational efficiency by enabling seamless, real-time exchange of location information among surrounding road users. This development represents a continued...

Geneva, Switzerland, Jan. 27, 2026 (GLOBE NEWSWIRE) — SEALSQ Corp (NASDAQ: LAES) (“SEALSQ” or “Company”), a company that focuses on developing and selling Semiconductors, PKI, and Post-Quantum technology hardware and software products, today announced that it is redefining vertical integration in the quantum era by building a platform where trust begins, in silicon. Rather than developing quantum solutions in isolated layers of hardware, software, or connectivity, SEALSQ has designed a fully integrated architecture in which cryptographic identity, post-quantum security, and sovereignty are embedded at the hardware level from the outset. This ensures that security and trust are intrinsic properties of the system, not external add-ons. The initiative began with a pilot Quantum Corridor linking three strategic...

Precise MRD™ to transition from research-use-only into a limited clinical launch in March 2026 SALT LAKE CITY, Jan. 27, 2026 (GLOBE NEWSWIRE) — Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, today announced a commercialization roadmap for its Precise MRD™ (molecular residual disease) assay and highlighted compelling data that reinforces the clinical value of ultrasensitive circulating tumor DNA (ctDNA) detection across cancer types. Myriad will launch Precise MRD with select community-based clinicians in March 2026 in breast, followed by colorectal and renal cancers later this year. The company may expand into additional cancer types, including ovarian and endometrial in 2027 and beyond. “Our Precise MRD program reflects Myriad’s unwavering commitment to advancing...

Press Release         Atos Named as a Leader in the ISG Provider Lens™ for AI-Driven Application Managed Services and Application Development Outsourcing Paris, France, January 27, 2026 – Atos, a global leader in AI-powered digital transformation, has been named by Information Services Group (ISG), the leading global research and advisory firm as a Leader in European AI-Driven Application Managed Services, and AI-Driven Application Development Outsourcing.  This comprehensive vendor assessment covered 29 Service Providers, with Atos sharing the top Leader ranking with vendors such as Accenture, Capgemini, and Deloitte.  The report highlights the rapid evolution of GenAI as the foundation of next-generation ADM services, where leading vendors such as Atos are successfully embedding capabilities like the Atos Polaris AI Platform to...

CAMBRIDGE, Mass., Jan. 27, 2026 (GLOBE NEWSWIRE) — Ernexa Therapeutics (Nasdaq: ERNA), an industry innovator developing novel cell therapies for the treatment of advanced cancer and autoimmune disease, today announced it has been selected as one of only ten companies worldwide to participate in the Japan Entry Acceleration Program (JEAP), a highly competitive initiative launched by the Japan External Trade Organization (JETRO). JEAP drew approximately 70 regenerative medicine companies from 25 countries, underscoring the competitiveness of the selection process. Ernexa was chosen for its differentiated cell therapy platform and its potential to contribute meaningfully to Japan’s globally recognized regenerative medicine and oncology ecosystem. Notably, six of the ten selected companies focus on oncology, placing Ernexa among an...

Key Milestone Builds Toward Doubling Patent Portfolio to Over 200 Worldwide – Positioning Propanc as a Long-Term Leader in Metastatic Cancer Prevention MELBOURNE, Australia, Jan. 27, 2026 (GLOBE NEWSWIRE) — Propanc Biopharma, Inc. (Nasdaq: PPCB) (“Propanc” or the “Company”), a biopharmaceutical company focused on developing novel treatments for chronic diseases, including recurrent and metastatic cancer, today announced the filing of its fourth new provisional patent application in the past two months with IP Australia. This latest application focuses on innovative formulations of the pancreatic proenzymes, trypsinogen and chymotrypsinogen— the active components in Propanc’s lead asset, PRP — addressing critical challenges in stability, storage, freeze/thaw cycling, and global transport. These advancements overcome longstanding...

MLPI and smart zone management strengthen mobility across large campus sites SALT LAKE CITY, Jan. 27, 2026 (GLOBE NEWSWIRE) — OMNIQ CORP (OTCMKTS: OMQS) (“OMNIQ” or “the Company”), a leader in AI-based computer vision and data intelligence, has been contracted to provide LPR solutions for a major technology innovator. The customer is one of the world’s most influential technology companies, supported by tens of thousands of employees across the broader Silicon Valley region. Its sprawling campuses require reliable, efficient, and highly secure mobility and access solutions. The company is deploying OMNIQ LPR technology across multiple campuses to support a more efficient and secure mobility experience. The solution includes MLPI, the mobile AI-based license plate inventory system that gives the customer real-time visibility across...

TEL AVIV, Israel, Jan. 27, 2026 (GLOBE NEWSWIRE) — HUB Cyber Security Ltd. (Nasdaq: HUBC) (“HUB” or the “Company”), a global leader in confidential computing and secured data fabric technologies, today announced that it received a letter from The Nasdaq Stock Market LLC (“Nasdaq”), notifying the Company that it is currently not in compliance with Nasdaq Listing Rule 5550(b)(2), which requires the Company to maintain a minimum Market Value of Listed Securities of US$35 million (“MVLS”) for continued listing on The Nasdaq Capital Market (the “MVLS Requirement”). This press release is issued pursuant to Nasdaq Listing Rule 5810(b), which requires prompt disclosure of receipt of a deficiency notification. The notification has no immediate effect on the listing of the Company’s ordinary shares, which will continue to trade uninterrupted...